Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein

Digestion. 1997;58(2):176-80. doi: 10.1159/000201441.

Abstract

This study comprised 62 outpatients with ulcerative colitis who underwent 64 colonoscopies. The disease activity was evaluated according to endoscopic and histological criteria. The results revealed a significant correlation between both the endoscopic as well as the histological gradings of disease activity and faecal calprotectin. The median faecal calprotectin levels in the control group (6 mg/l) and in the patients with no or low disease activity (11.5 mg/l) were significantly different (p < 0.0001). The median calprotectin level among patients with active disease was 68 mg/l which was significantly different from the latter group (p < 0.0001). Furthermore, we suggest that the degree of inflammation rather than the extent of the disease determined the faecal calprotectin levels. In conclusion, assessment of faecal calprotectin seems to be a marker of disease activity in patients with ulcerative colitis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / analysis
  • Blood Platelets / chemistry
  • Blood Proteins / analysis
  • Blood Proteins / metabolism
  • Blood Sedimentation
  • Colitis, Ulcerative / diagnosis
  • Colitis, Ulcerative / metabolism*
  • Colonic Diseases / metabolism
  • Endoscopy
  • Feces / chemistry*
  • Female
  • Granulocytes / chemistry*
  • Hemoglobins / analysis
  • Hemoglobins / metabolism
  • Histocytochemistry
  • Humans
  • Leukocyte L1 Antigen Complex
  • Male
  • Middle Aged
  • Neural Cell Adhesion Molecules / metabolism*
  • Serum Albumin / analysis

Substances

  • Biomarkers
  • Blood Proteins
  • Hemoglobins
  • Leukocyte L1 Antigen Complex
  • Neural Cell Adhesion Molecules
  • Serum Albumin